GLP-1 medicines don't just change your body. They can also change your desires, moods, thoughts, and relationships. Will you ...

Quick Links hide Kaplan USMLE Step 1 Prep Course Bottom Line Bottom Line Lecturio USMLE Question Banks Bottom Line USMLE ...

A Nature Medicine paper landed on Feb. 2 like a stone in a pond, sending out ripples that quickly turned into tidal waves across biomedical circles. By midday, renowned physician-scientist Eric Topol, ...

UC San Diego is leading the way in exploring whether popular GLP-1 drugs consisting of semaglutide — like Ozempic and Wegovy — can slow biological aging. Their new federally funded study provides the ...

A study commissioned by President Joe Biden's administration to investigate alcohol-related health harms was released independently on Tuesday, after President Donald Trump's administration decided ...

Add Yahoo as a preferred source to see more of our stories on Google. It's a development millions of people living with Type 1 diabetes never thought would happen. A new study is showing promising a ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Lung cancer is among the conditions that may be affected. GLP-1 medications such as Wegovy, ...

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting. Subscribe to ...

Are GLP-1 weight loss drugs like Ozempic the miracle many have waited for, or are used guinea pigs in an experiment they’ll regret in a decade? That’s the central question of a discussion Wednesday on ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. GLP-1s are ...

Investigator-assessed PFS improved with atirmociclib plus fulvestrant versus fulvestrant alone or everolimus/exemestane, achieving HR 0.60 and meeting the primary endpoint with clinically meaningful ...